HCA Healthcare Inc (NYSE:HCA) – Equities research analysts at Piper Jaffray Companies lifted their FY2019 earnings estimates for shares of HCA Healthcare in a report released on Tuesday, April 30th. Piper Jaffray Companies analyst S. James now anticipates that the company will post earnings per share of $10.16 for the year, up from their prior estimate of $9.87. Piper Jaffray Companies also issued estimates for HCA Healthcare’s Q1 2020 earnings at $3.10 EPS and FY2020 earnings at $11.15 EPS.

Several other brokerages also recently issued reports on HCA. Oppenheimer increased their price target on HCA Healthcare from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. Leerink Swann increased their price target on HCA Healthcare from $160.00 to $175.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. SunTrust Banks increased their price target on HCA Healthcare to $175.00 and gave the company a “buy” rating in a report on Wednesday, January 30th. Stephens assumed coverage on HCA Healthcare in a report on Monday, January 14th. They issued an “overweight” rating and a $143.00 price target for the company. Finally, ValuEngine downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and nineteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $149.41.

Shares of NYSE HCA opened at $126.15 on Friday. HCA Healthcare has a 12-month low of $94.23 and a 12-month high of $147.42. The firm has a market capitalization of $43.70 billion, a P/E ratio of 12.91, a P/E/G ratio of 1.06 and a beta of 0.75.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The firm had revenue of $12.52 billion during the quarter, compared to the consensus estimate of $12.34 billion. During the same period in the prior year, the firm earned $3.18 EPS. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year.

Several hedge funds have recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $25,000. Sontag Advisory LLC bought a new stake in HCA Healthcare during the fourth quarter worth approximately $26,000. Moody National Bank Trust Division bought a new stake in HCA Healthcare during the fourth quarter worth approximately $27,000. Doyle Wealth Management bought a new stake in HCA Healthcare during the fourth quarter worth approximately $31,000. Finally, Trust Co. of Vermont boosted its holdings in HCA Healthcare by 165.3% during the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock worth $41,000 after buying an additional 205 shares in the last quarter. 71.48% of the stock is currently owned by institutional investors and hedge funds.

In other news, SVP J William Morrow sold 263 shares of the stock in a transaction dated Thursday, February 7th. The shares were sold at an average price of $140.60, for a total transaction of $36,977.80. Following the transaction, the senior vice president now owns 5,922 shares of the company’s stock, valued at $832,633.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Victor L. Campbell sold 28,084 shares of the stock in a transaction dated Monday, February 11th. The stock was sold at an average price of $138.97, for a total transaction of $3,902,833.48. Following the transaction, the senior vice president now directly owns 231,493 shares in the company, valued at approximately $32,170,582.21. The disclosure for this sale can be found here. Over the last three months, insiders sold 77,953 shares of company stock valued at $10,867,368. 2.70% of the stock is currently owned by corporate insiders.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Monday, June 3rd will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.60 dividend on an annualized basis and a yield of 1.27%. HCA Healthcare’s payout ratio is currently 16.38%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Fundamental Analysis and Individual Investors

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.